Preclinical biotech developing novel therapies based on red blood cells.
Industry: Health Care
First Day Return: +5.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/22/2018 |
Offer Price | $23.00 |
Price Range $20.00 - $22.00 | |
Offer Shares (mm) | 10.5 |
Deal Size ($mm) | $241 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/17/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $241 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2013 |
Employees at IPO | 83 |
Website www.rubiustx.com |